- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

H.R. 7777
U.S. House•In House Committee
Summary
H.R. 7777, the Protecting America’s Medical Supply Chains Act of 2026, was introduced in the House on Mar 3, 2026 by Rep. Maria Salazar (R). It was referred to Financial Services, and last saw action on Mar 3, 2026: Referred to the House Committee on Financial Services.
Record
Text
H.R. 7777 has no co-sponsors and has not gone to a roll call.
hb7777/introduced-in-house.txt119 HR 7777 IH: Protecting America’s Medical Supply Chains Act of 2026U.S. House of Representatives2026-03-03text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.I 119th CONGRESS 2d Session H. R. 7777 IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services A BILLTo amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes.1.Short titleThis Act may be cited as the Protecting America’s Medical Supply Chains Act of 2026 .2.Securing essential medical materials(a)Statement of policySection 2(b) of the Defense Production Act of 1950 ( 50 U.S.C. 4502 ) is amended—(1)by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and(2)by inserting after paragraph (2) the following:(3)authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;.(b)Strengthening domestic capabilitySection 107 of the Defense Production Act of 1950 ( 50 U.S.C. 4517 ) is amended—(1)in subsection (a), by inserting (including medical materials) after materials ; and(2)in subsection (b)(1), by inserting (including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. )), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act ( 42 U.S.C. 262 )) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense) after essential materials .(c)Strategy on securing supply chains for medical materialsTitle I of the Defense Production Act of 1950 ( 50 U.S.C. 4511 et seq. ) is amended by adding at the end the following:109.Strategy on securing supply chains for medical materials(a)In generalNot later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following:(1)A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. )), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act ( 42 U.S.C. 262 )) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act.(2)An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities.(3)Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense.(4)A discussion of—(A)any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs;(B)a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and(C)efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies.(b)Progress ReportFollowing submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex.(c)Appropriate Members of CongressIn this section, the term appropriate Members of Congress means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate..3.Investment in supply chain security(a)In generalSection 303 of the Defense Production Act of 1950 ( 50 U.S.C. 4533 ) is amended by adding at the end the following:(h)Investment in supply chain security(1)In generalIn addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States.(2)Eligible entityAn eligible entity described in this paragraph is an entity that—(A)is organized under the laws of the United States or any jurisdiction within the United States; and(B)produces—(i)one or more critical components;(ii)critical technology; or(iii)one or more products or raw materials for the security of supply chains or supply chain activities.(3)DefinitionsIn this subsection, the terms supply chain and supply chain activities have the meanings given those terms by the President by regulation..(b)Regulations(1)In generalNot later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms supply chain and supply chain activities for the purposes of section 303(h) of the Defense Production Act of 1950 ( 50 U.S.C. 4533(h) ), as added by subsection (a).(2)Scope of definitionsThe definitions required by paragraph (1)—(A)shall encompass—(i)the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or(ii)critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and(B)may include variations as determined necessary and appropriate by the President for purposes of national defense.
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2026-03-03
- Passed House
- Passed Senate
- Conference
- To President
- Became Law
To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes.
Sponsors
Rep. Maria Salazar (R) sponsors H.R. 7777 alone.
Committees
H.R. 7777 went before 1 committee: Financial Services.
Actions
H.R. 7777 has taken 2 actions since Mar 3, 2026.
| Chamber | Action | |||
|---|---|---|---|---|
Mar 3, 2026 | House | Introduced in House | ||
Mar 3, 2026 | House | Referred to the House Committee on Financial Services.Financial Services Committee |
Votes
H.R. 7777 has not gone to a roll call.
Titles
H.R. 7777 goes by 3 titles, 1 of them short titles.
- Protecting America’s Medical Supply Chains Act of 2026 — Display Title
- Protecting America’s Medical Supply Chains Act of 2026 — Short Title(s) as Introduced
- To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. — Official Title as Introduced
Classification
The Congressional Research Service files H.R. 7777 under Government Operations and Politics, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; H.R. 7777’s is Government Operations and Politics.
hr7777/policy-areas.txtConstitutional authority
The clause the sponsor cites as Congress’s power to enact H.R. 7777, as entered in the Congressional Record.
[Congressional Record Volume 172, Number 40 (Tuesday, March 3, 2026)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SALAZAR:H.R. 7777.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8[Page H2370]
Source: congress.gov · legiscan.com